10-54195684-T-G

Variant summary

Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBA1

The NM_001384140.1(PCDH15):​c.1304A>C​(p.Asp435Ala) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.177 in 1,610,574 control chromosomes in the GnomAD database, including 39,899 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. D435?) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.18 ( 3801 hom., cov: 32)
Exomes 𝑓: 0.18 ( 36098 hom. )

Consequence

PCDH15
NM_001384140.1 missense, splice_region

Scores

1
9
8
Splicing: ADA: 0.9938
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 7.99
Variant links:
Genes affected
PCDH15 (HGNC:14674): (protocadherin related 15) This gene is a member of the cadherin superfamily. Family members encode integral membrane proteins that mediate calcium-dependent cell-cell adhesion. It plays an essential role in maintenance of normal retinal and cochlear function. Mutations in this gene result in hearing loss and Usher Syndrome Type IF (USH1F). Extensive alternative splicing resulting in multiple isoforms has been observed in the mouse ortholog. Similar alternatively spliced transcripts are inferred to occur in human, and additional variants are likely to occur. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -15 ACMG points.

PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
BP6
Variant 10-54195684-T-G is Benign according to our data. Variant chr10-54195684-T-G is described in ClinVar as [Benign]. Clinvar id is 46440.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-54195684-T-G is described in Lovd as [Benign]. Variant chr10-54195684-T-G is described in Lovd as [Likely_pathogenic].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.822 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCDH15NM_033056.4 linkc.1304A>C p.Asp435Ala missense_variant, splice_region_variant Exon 11 of 33 ENST00000320301.11 NP_149045.3 Q96QU1-1
PCDH15NM_001384140.1 linkc.1304A>C p.Asp435Ala missense_variant, splice_region_variant Exon 11 of 38 ENST00000644397.2 NP_001371069.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCDH15ENST00000320301.11 linkc.1304A>C p.Asp435Ala missense_variant, splice_region_variant Exon 11 of 33 1 NM_033056.4 ENSP00000322604.6 Q96QU1-1
PCDH15ENST00000644397.2 linkc.1304A>C p.Asp435Ala missense_variant, splice_region_variant Exon 11 of 38 NM_001384140.1 ENSP00000495195.1 A0A2R8Y6C0

Frequencies

GnomAD3 genomes
AF:
0.176
AC:
26747
AN:
152036
Hom.:
3799
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.131
Gnomad AMI
AF:
0.140
Gnomad AMR
AF:
0.212
Gnomad ASJ
AF:
0.135
Gnomad EAS
AF:
0.843
Gnomad SAS
AF:
0.370
Gnomad FIN
AF:
0.143
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.139
Gnomad OTH
AF:
0.176
GnomAD3 exomes
AF:
0.240
AC:
60262
AN:
251270
Hom.:
11768
AF XY:
0.240
AC XY:
32557
AN XY:
135802
show subpopulations
Gnomad AFR exome
AF:
0.130
Gnomad AMR exome
AF:
0.289
Gnomad ASJ exome
AF:
0.139
Gnomad EAS exome
AF:
0.843
Gnomad SAS exome
AF:
0.349
Gnomad FIN exome
AF:
0.144
Gnomad NFE exome
AF:
0.143
Gnomad OTH exome
AF:
0.208
GnomAD4 exome
AF:
0.178
AC:
258923
AN:
1458420
Hom.:
36098
Cov.:
30
AF XY:
0.182
AC XY:
132192
AN XY:
725766
show subpopulations
Gnomad4 AFR exome
AF:
0.130
Gnomad4 AMR exome
AF:
0.280
Gnomad4 ASJ exome
AF:
0.139
Gnomad4 EAS exome
AF:
0.870
Gnomad4 SAS exome
AF:
0.341
Gnomad4 FIN exome
AF:
0.146
Gnomad4 NFE exome
AF:
0.138
Gnomad4 OTH exome
AF:
0.202
GnomAD4 genome
AF:
0.176
AC:
26758
AN:
152154
Hom.:
3801
Cov.:
32
AF XY:
0.186
AC XY:
13838
AN XY:
74358
show subpopulations
Gnomad4 AFR
AF:
0.131
Gnomad4 AMR
AF:
0.213
Gnomad4 ASJ
AF:
0.135
Gnomad4 EAS
AF:
0.843
Gnomad4 SAS
AF:
0.369
Gnomad4 FIN
AF:
0.143
Gnomad4 NFE
AF:
0.139
Gnomad4 OTH
AF:
0.180
Alfa
AF:
0.162
Hom.:
7404
Bravo
AF:
0.182
TwinsUK
AF:
0.129
AC:
478
ALSPAC
AF:
0.143
AC:
551
ESP6500AA
AF:
0.131
AC:
579
ESP6500EA
AF:
0.132
AC:
1133
ExAC
AF:
0.238
AC:
28895
Asia WGS
AF:
0.575
AC:
1995
AN:
3478
EpiCase
AF:
0.146
EpiControl
AF:
0.145

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 08, 2019
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 19816713, 27275418, 22815625) -

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 23, 2009
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jun 21, 2017
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Usher syndrome type 1F Benign:3
Jul 01, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 28, 2019
Mendelics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Usher syndrome type 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.11
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Benign
0.054
T;.;.;.;.;T;.;T;.;T;T;.;.;T;.;T;.;.;.;.;.;.;T;.
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.52
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.93
D;D;D;D;D;D;T;D;D;T;T;T;D;T;D;D;D;D;D;D;D;D;D;D
MetaRNN
Benign
0.0000011
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.7
.;.;.;.;L;.;.;.;.;.;.;L;.;.;.;.;.;.;.;.;.;.;L;L
PrimateAI
Uncertain
0.49
T
PROVEAN
Uncertain
-3.2
D;.;.;D;.;.;N;.;D;D;.;D;D;.;D;.;.;D;D;D;.;D;D;D
REVEL
Benign
0.21
Sift
Uncertain
0.0090
D;.;.;D;.;.;D;.;T;D;.;D;D;.;T;.;.;D;D;D;.;T;D;D
Sift4G
Uncertain
0.0090
D;.;D;D;D;D;T;D;T;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen
0.87, 0.97, 0.88, 0.99, 0.99, 0.95, 0.84
.;.;.;.;.;.;.;.;.;.;.;.;P;.;D;.;.;P;D;D;.;D;P;P
Vest4
0.53
MPC
0.13
ClinPred
0.020
T
GERP RS
5.1
Varity_R
0.23
gMVP
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.99
dbscSNV1_RF
Pathogenic
0.95
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4935502; hg19: chr10-55955444; COSMIC: COSV57312908; API